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Mammary ductal carcinoma in-situ (DCIS), a malignant appearing lesion on cytological and histological grounds, is in fact a
non-obligate precancer. DCIS is diﬃcult to manage and is sometimes treated more aggressively than invasive carcinoma. Although
most DCIS classiﬁcations take into account the architectural growth pattern, when it comes to architecture, the literature is full of
contradictory information. We examined 289 breast cancers and found DCIS in 265 of the cases. The majority of the DCIS cases
were seen in the setting of invasive cancer and only 9% of the cases represented pure DCIS with no invasive cancer. The DCIS
commonly displayed a mixed pattern with micropapillary, cribriform and solid components with the micropapillary type being
the rarest, occurring seldom on its own. A continuum of growth with a micropapillary pattern evolving into a cribriform type
could be seen in some of the cases. This may explain some of the conﬂicting information, in the literature, regarding the diﬀerent
architectural types of DCIS. The comedo-pattern of necrosis could be seen in all types of DCIS. We therefore conclude that the
study of the determinants of growth pattern in DCIS would be the key to unravelling the diverse, often non-concordant evidence
one encounters in the literature.
1.Introduction
Classifying and managing DCIS has always been a thorny
issue, often dividing various groups of pathologists around
the world [1].
Amongst DCIS features, the architectural pattern, its
prognostic value, and role in grading DCIS have also been
stirring suﬃcient controversy. The current literature on the
subjectacceptstheexistenceof3majorarchitecturalpatterns
of DCIS, namely, the solid, cribriform, and micropapillary
patterns [2].
The clinging or ﬂat type is not universally accepted as
fully developed DCIS. It has been variably considered as
an early micropapillary DCIS or even a subvariant of the
atypical ductal hyperplasia [3].
Other special types of DCIS, such as the apocrine,
the endocrine (argyrophilic), and signet ring DCIS, are all
deﬁned on histological criteria, rather than architectural pat-
tern and they actually belong to the solid pattern of growth.
With respect to grading, it is universally accepted that the
nuclear grade is the essential feature, recurring in all classiﬁ-
cation systems previously proposed and currently in use [4].
An association, albeit inconsistent, exists between the
nuclear grade and the architectural growth pattern. It is
generally accepted that most micropapillary and cribriform
in situ carcinomas are of low nuclear grade and relatively
indolent [5]. However, in a recent publication by Fisher and
colleagues, micropapillary DCIS was found to be associated
with both ipsilateral and contralateral recurrence of malig-
nancy in a statistically signiﬁcant number of cases [6].
As this result appears somewhat puzzling in the light
of our present knowledge and understanding of DCIS, we
decidedtohaveanew,freshlookatallcasesofDCISreported
during the past approximately 10 years at the Department of2 International Journal of Surgical Oncology
Pathology of the Royal Darwin Hospital, NT, Australia and
report our ﬁndings.
2.MaterialsandMethods
All cases of DCIS reported at the Royal Darwin Hospital,
Northern Territory, Australia between January 2001 and
September 2010, representing 60% of all breast cancers in
the NT were retrospectively reviewed. In order to capture
all the cases, including those that may have been incorrectly
coded, we veriﬁed all breast tissue reports and then selected
for active review all cases of DCIS. The architectural and
cytological aspects of DCIS were assessed. The presence or
absence of necrosis was also evaluated.
2.1. Architecture. The 3 main types of DCIS, according to
the architectural growth pattern (micropapillary, cribriform,
and solid) were assessed. Architecturally DCIS was divided
into single, when >90% of the in situ tumour displayed one
architectural pattern, and mixed when the dominant pattern
constituted <90% of the in situ carcinoma.
2.2. Nuclear Grade. Nuclear grading is based on the size
of malignant cells nuclei in comparison to normal ductal
epithelial cells. Grade 1 is applied when the nuclei of the
malignant cell are between 1.5 and 2 times that of normal
ductal epithelial cell. Grade 2 is applied when the nuclei of
themalignant cellare between 2 and 2.5 times thatof normal
ductal epithelial cell. Grade 3 is applied when the nuclei of
the malignant cell are greater than 2.5 times that of normal
ductal epithelial cell [7].
2.3. Necrosis. Any necrosis in DCIS was recorded. Minimal
necrosis was labelled as necrosis, not otherwise speciﬁed.
The term comedonecrosis, which is poorly deﬁned in the
literature, was applied when signiﬁcant necrosis, creating an
appearancesimilarthecomedos,seenincutaneousacne,was
noted in ducts with DCIS.
3. Results
A total of 289 breast carcinomas had been received at the
Royal Darwin Hospital during the period of the study. These
consisted of 265 invasive and 24 pure in situ cancers.
These cancers consisted of 231 inﬁltrating duct carcino-
masofnospecialtype,24inﬁltratinglobularcarcinomasand
10carcinomasofspecialtype.Ofthesespecialbreastcancers,
5 were pure mucinous carcinomas, 2 were invasive papillary
carcinomas, 2 were tubular carcinomas, and 1 was medullary
carcinoma.
DCIS was present in 133/265 (50.18%) of the invasive
ductal carcinomas. The proportion of invasive ductal carci-
nomas containing DCIS varied from year to year, ranging
from 16/26 (62%) in 2002 to 8/26 (31%) in 2007. The reason
for this variation is not clear.
3.1. DCIS Subtypes. Table 1 also shows the frequency of pure
DCIS and DCIS associated with invasive cancer.
Table 1: DCIS pure and with invasive cancer and growth pattern.
DCIS growth pattern (157 cases)
Single 91 (58%)
Mixed 66 (42%)
DCIS with a single growth pattern (91 cases)
Micropapillary 4 (5%)
Cribriform 23 (25%)
Solid 61 (67%)
Macropapillary/encysted papillary 3 (3%)
DCIS with a mixed growth pattern (66 cases)
Micropapillary, cribriform, and solid 11 (17%)
Micropapillary and cribriform 14 (21%)
Micropapillary and solid 11 (17%)
Cribriform and solid 30 (45%)
Table 2: DCIS by growth pattern.
Micropapillary (40 cases)
Pure micropapillary DCIS without cancer 0
Pure micropapillary DCIS with invasive cancer 4
Cribriform (78 cases)
Pure cribriform DCIS without cancer 2
Pure cribriform DCIS with invasive cancer 21
Solid (113 cases)
Pure solid DCIS without cancer 7
Pure solid DCIS with invasive cancer 54
Mixed DCIS (66 cases)
Mixed DCIS without cancer 12
Mixed DCIS with invasive cancer 54
Macropapillary (3 cases)
Pure macropapillary DCIS without cancer 3
Pure macropapillary DCIS with invasive cancer 0
Ofthe157casesofDCIS(pureDCISandinvasivecancers
with DCIS), 91 (58%) displayed a single growth pattern and
66 (42%) showed a mixed growth pattern (Table 1).
Of the 91 cases of DCIS with a single growth pattern,
4 (5%) were micropapillary, 23 (25%) were cribriform,
61 (67%) were solid, and 3 (3%) were encysted papillary
(Table 1).
Of the 66 mixed type DCIS cases, all 3 growth patterns
(micropapillary, cribriform, and solid) were noted in 11
(17%) of the cases. Micropapillary and cribriform was
present in 14 (21%), micropapillary and solid was seen in 11
(17%), and cribriform and solid was identiﬁed in 30 (45%)
of the cases (Table 1).
Most of the pure in situ carcinomas were of the mixed
type and there were no cases of single pattern micropapillary
DCIS (Table 2).
Overall, a micropapillary pattern was seen in 40/157
(25%), a cribriform component in 78/157 (50%), a solid
component in 113/157 (72%), and macropapillary (encysted
papillary carcinoma) in 3 (1.9%) of the DCIS cases (Table 2).International Journal of Surgical Oncology 3
Table 3: DCIS by nuclear grade.
All cases with any micropapillary DCIS
component (40 cases)
Low grade 2 (5%)
Intermediate grade 18 (45%)
High grade 20 (50%)
All cases with any cribriform DCIS component
(78 cases)
Low grade 17 (22%)
Intermediate grade 39 (50%)
High grade 22 (28%)
All cases with any solid DCIS component
(113 cases)
Low grade 8 (7%)
Intermediate grade 47 (42%)
High grade 58 (51%)
All cases with any mixed DCIS component
(66cases)
Low grade 8 (12%)
Intermediate grade 30 (45%)
High grade 28 (43%)
Macropapillary (3 cases)
Low grade 3 (100%)
Intermediate grade 0 (0%)
High grade 0 (0%)
3.2. Comedonecrosis. Comedonecrosis was present in 18/40
(45%) of the micropapillary, 67/113 (59%) of the solid,
and 20/78 (26%) of the cribriform cases of DCIS. These
ﬁndings show that comedonecrosis is more likely to be
seen in micropapillary and solid types DCIS than in the
cribriform type. This association is statistically signiﬁcant
with P values of 0.033 and 0.00004, respectively. At the same
time, no statistically signiﬁcant diﬀerence in comedonecrosis
occurrence was noted between the micropapillary and solid
DCIS (P = 0.117).
3.3. Nuclear Grade. Of the 157 cases of DCIS high nuclear
grade was recognised in 70 (45%), intermediate nuclear
grade in 65 (41%), and low nuclear grade in 22 (14%) of the
cases (Table 3).
3.4. Nuclear Grade versus Architectural Type of DCIS. Of the
40 cases of micropapillary DCIS, 2 (5%) were low grade,
18 (45%) were intermediate grade, and 20 (50%) were high
grade (Table 3).
Of the 78 cases of cribriform DCIS, 17 (22%) were low
grade, 39 (50%) were intermediate grade, and 22 (28%) were
high grade (Table 3).
Of the 113 cases of solid DCIS, 8 (7%) were low grade,
47 (42%) were intermediate grade, and 58 (51%) were high
grade (Table 3).
These results show a statistically signiﬁcant diﬀerence
between the presence of high nuclear grade (grade 3) in
the solid and micropapillary types of DCIS compared to
the cribriform type (P = 0.0008, and P = 0.019 resp.).
On the other hand, no statistically signiﬁcant nuclear grade
diﬀerences were noted between the micropapillary and solid
types (P = 0.884).
All three cases of macropapillary (encysted papillary
carcinoma) were low grade (Table 3).
3.5. Micropapillary DCIS. Overall, we identiﬁed 40 cases
with a micropapillary DCIS component (Table 2). Thirty-
six of these were mixed with other growth patterns and
4 had only micropapillary growth pattern. In the cases of
DCIS with no invasive cancer, there was a micropapillary
component in 9 cases; all mixed with other growth patterns.
The remaining 31 cases of micropapillary DCIS had an
associated invasive component. Of these, 4 had only a
micropapillary growth and in 27 the micropapillary pattern
was mixed with other growth patterns.
Of all the 91 cases of DCIS with a single growth pattern,
4 (4%) had only micropapillary growth (Table 1). Of the 24
cases of pure DCIS, none was only micropapillary but 9 had
a micropapillary component, mixed with other architectural
patterns. Of these, 6 cases were high grade, 2 cases were
intermediate grade, and 1 case was low grade (Table 3).
Theageofpatientswhohadamicropapillarycomponent
r a n g e df r o m3 8y e a r st o8 8y e a r sw i t ham e d i a no f5 0y e a r s .
The age range for the low grade was 52 years to 63 years, for
the intermediate grade was 38 years to 88 years, and for the
high grade was 40 years to 80 years.
The invasive component of cases that included a
micropapillarytypeDCISwasgrade3in22.6%(7/31),grade
2in38.7%(12/31),andgrade1in38.7%(12/31)ofthecases.
Of the 4 cases with micropapillary DCIS not associated
with any other type of DCIS (pure micropapillary type), 3
were intermediate grade and 1 was low grade. There were no
high grade cases (Table 3).
The micropapillary DCIS represented only a minor
component (<25%) in 9/36 of the cases in which it appeared
in combination with the other types of DCIS.
3.6. Concordance between the Original Assessment and the
Current Review. The cases had been reported by 6 pathol-
ogists, of which three were responsible for reporting 94%
of cases. The overall concordance for all cases of DCIS, in
respect to nuclear grade, regardless of architectural pattern,
was very good, with a Kappa score of 0.87.
Incaseswithmicropapillarycomponenttherewasagood
concordance between our evaluation and the initial report
with a Kappa score of 0.61. The nonconcordant cases, which
diﬀered by 1 grade, were all between low to intermediate
grade; none involved a high grade.
Theconcordancerateforcasesnotincludingamicropap-
illary pattern was also very good with a Kappa score of 0.88.
4. Discussion
It is beyond the scope of this study to chronologically reca-
pitulate all aspects of this complex histopathological entity.4 International Journal of Surgical Oncology
Regarding the micropapillary DCIS, our results are sur-
prising,butmayexplainpartlytheincreasedcorrelationwith
breast carcinoma recurrence identiﬁed by Fisher et al. [6].
Fisher and colleaguesreviewing DCIS from1456 patients
enrolled in the National Surgical Adjuvant Breast and Bowel
Project (NSABP) protocol B-24 to determine predictors for
ipsilateralbreasttumourrecurrencesandcontralateralbreast
cancers, after a median follow-up time of 10.5 years, found
ductal comedonecrosis, micropapillary histological tumour
type to be independent high risk factors for ipsilateral breast
tumour recurrence and for contralateral breast cancers [6].
In a recent article, Castellano et al. have shown the
nuclear grade to be crucial in determining the biology of
micropapillary DCIS. They also showed that high nuclear
grade micropapillary DCIS more frequently overexpressed
HER2, showed a higher proliferation index, and displayed
necrosis and microinvasion. Logistic regression analysis
conﬁrmed high nuclear grade (odds ratio, 6.86; conﬁdence
interval, 1.40–33.57) as the only parameter associated with
elevated risk of local recurrence after breast-conserving
surgery. However, the recurrence rate of 19 micropapillary
DCIS, which were part of a cohort of 338 consecutive DCIS,
was signiﬁcantly higher (log-rank test, P = 0.019) than that
of nonmicropapillary, independent of nuclear grade. The
authors concluded that although nuclear grade may signif-
icantly inﬂuence the biological behaviour of micropapillary
ductal carcinoma in situ, micropapillary growth pattern
represents a risk factor for local recurrence after breast-
conserving surgery [8].
The micropapillary pattern of DCIS is by far the rarest
one in our study. It was seldom seen on its own. While the
number of cases in which the micropapillary growth pattern
constitutes the only pattern was very small in our study,
it may not be a coincidence that none of these cases was
high nuclear grade and none was associated with necrosis.
This ﬁnding would be consistent with the dogma deﬁning
micropapillary DCIS as a predominantly low grade DCIS.
The frequent association between micropapillary DCIS
and necrosis may explain why authors, considering come-
donecrosis a separate pattern of DCIS, have been discarding
all those cases also displaying comedonecrosis from the
micropapillary group [8].
Another notion on which all publications seem to agree
is the fact that the solid variant tends to be associated with
high grade DCIS, whereas the micropapillary and cribriform
variants most often form a low grade DCIS [5].
We believe comedocarcinoma is not a separate type of
DCIS and should not be used as such. In other words,
each DCIS should be given an architectural pattern label
and the presence or absence of necrosis should be described
separately.
In all the cases of DCIS with a pure micropapillary
growth pattern, the nuclear grade was low or intermediate.
This may mean that those cases of low grade DCIS that
may have a certain genetic makeup will maintain an indolent
course, whereas the more aggressive ones will undergo the
changes described above and assume a mixed growth pattern
with comedonecrosis.
Because of this supposed evolution, the micropapillary
component may represent a minor proportion of the entire
DCIS at the time the tissue is removed for histological
evaluation.
If comedocarcinoma is considered a separate type of
DCIS in which the architectural pattern is neglected and not
reported,thenourresults,withonly4casesofmicropapillary
DCIS, are all in keeping with the old dogma that micropap-
illary DCIS is a low or intermediate grade with no necrosis.
We agree with Fisher and colleagues [6] in considering
comedocarcinoma a separate feature, rather than a histolog-
ical type.
Pinder and O’Malley [9] hit the nail on the head and
explain that comedonecrosis may be seen in association with
any DCIS architectural type, and that it is not a type itself,
as it is “neither a grade nor an architectur.” So they clearly
recommend that the term comedo-type DCIS should not be
used as a characterisation of growth pattern. This is exactly
what we feel and what our study supports.
Also in keeping with our view is the fact that the rare,
special type DCIS, namely, the signet ring, endocrine, and
other types, also have a growth pattern that is, the solid one,
even if the cells show “speciﬁc” cytological features.
Our results show that over 40% (66/157) of the DCIS
cases are not of pure architectural type, but in fact they
are mixed. Approximately half of the solid (51%) and
micropapillary (50%) cases in our series are high grade.
These values are statistically signiﬁcant when compared to
the occurrence of high grade cribriform DCIS, of which only
2 8 %a r eh i g hg r a d e .
Just under half (45%) of the micropapillary and nearly
two-thirds (67%) of the solid cases of DCIS are associated
withcomedonecrosis,whileonlyaquarter(26%)ofthecrib-
riform cases of DCIS are associated with comedonecrosis.
These diﬀerences are also statistically signiﬁcant as shown
above. The micropapillary type is the rarest one, occurring
seldom as a pure form with less than 3% of all cases of DCIS
and less than 5% of DCIS cases with a single pattern being
pure micropapillary ones.
Slightly more than half (54%) of the solid and almost
a third (30%) of the cribriform cases occur on their own,
whereas in only 10% of the cases the micropapillary type
occurs on its own.
Low grade micropapillary and solid DCIS were very rare
in our series (5% and 7%, resp.).
Our results can be translated into the newly accepted
DIN system by replacing the nuclear grade value with the
equivalent DIN [10].
5. Conclusions
Aftercarefullyobservingandanalysingourdata,wedrawthe
conclusion that in many cases the pattern of growth may be
a continuum, starting as micropapillary, with papillae then
either joining one another to form arches resembling the
cribriform pattern or even continuing to proliferate until a
solid sheet of cells ﬁlls the entire lumen.International Journal of Surgical Oncology 5
As necrosis occurs toward the tips or on the sides of the
micropapillary structures, the lesion becomes intermediate
grade. With progression, nuclear pleomorphism and a
comedo-type necrosis appear, and the lesion then qualiﬁes
as a high grade DCIS.
We therefore believe the study of the determinants of
growth pattern in DCIS would be the key to unravelling the
diverse, often nonconcordant evidence one encounters in the
literature.
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